Milestone Scientific Appoints Dr. Dawood Sayed to Board of Directors to Advance Commercial and Clinical Strategy in Pain Management [Yahoo! Finance]
Milestone Scientific, Inc. (MLSS)
NASDAQ:AMEX Investor Relations:
ir.milestonescientific.com
Company Research
Source: Yahoo! Finance
ROSELAND, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of Dawood Sayed, M.D., a nationally recognized leader in interventional pain medicine, to its Board of Directors, effective immediately. Dr. Sayed is a Professor of Anesthesiology and Pain Medicine at the University of Kansas Medical Center and currently serves as Division Chief of Pain Medicine, Director of Interventional Spine Services, and Director of the Center for Neuromodulation. With a robust clinical, academic, and policy background, he brings over a decade of leadership in pioneering minimally invasive pain therapies, neuromodulation, and health system innovation. Dr. Sayed also serves as Vice Chairman and Co-Founder of the American Society of Pain and Neuroscience (ASPN), where he works closely with key stakeholders, including commercial paye
Show less
Read more
Impact Snapshot
Event Time:
MLSS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MLSS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MLSS alerts
High impacting Milestone Scientific, Inc. news events
Weekly update
A roundup of the hottest topics
MLSS
News
- Milestone Scientific (NYSE:MLSS) had its price target lowered by analysts at Benchmark Co. from $1.25 to $1.00. They now have a "speculative buy" rating on the stock.MarketBeat
- Milestone Scientific Inc (MLSS) Q3 2025 Earnings Call Highlights: Strategic Expense Reductions ... [Yahoo! Finance]Yahoo! Finance
- Milestone Scientific Inc. (MLSS) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Milestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference Call [Yahoo! Finance]Yahoo! Finance
- Milestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference CallGlobeNewswire
MLSS
Sec Filings
- 11/12/25 - Form DEF
- 10/29/25 - Form 4
- 10/23/25 - Form 4
- MLSS's page on the SEC website